Literature DB >> 3102595

Comparison of T cell receptor gene rearrangements in patients with large granular T cell leukemia and Felty's syndrome.

B Freimark, L Lanier, J Phillips, T Quertermous, R Fox.   

Abstract

Felty's syndrome (FS) refers to the occurrence of rheumatoid arthritis, splenomegaly, and neutropenia. A subset of these patients has recently been described with a chronic T cell leukemia of large granular lymphocytes (LGCL). To examine the spectrum of lymphocyte abnormalities in FS and LGCL, we examined phenotypic and genotypic properties of lymphocytes from eight FS patients. In two of these FS patients, we observed an elevated proportion of T cells with an unusual phenotype (CD3+/Leu-7+/Leu-8-/CR3+) (46 +/- 5% of mononuclear cells). The FS lymphocytes had large granular morphology on Wright-Giemsa stain and were active in antibody-dependent cellular cytotoxic activity. This phenotype, morphology, and activity was similar to LGCL patients except that the latter T cells additionally expressed the Fc-IgG receptor recognized by monoclonal antibody Leu-11 (CD 15). In the remaining six FS patients, the proportion of CD3+/Leu-7+/CR 3+ T cells was only 10 +/- 8%, which was not significantly different from age-matched normal subjects (6.6 +/- 2.2%). To determine the clonality of T lymphocytes in FS and LGCL, we examined DNA for rearrangements of the T cell antigen receptor beta-chain (Ti beta) and gamma-chain (Ti gamma) genes by using Southern blotting techniques. We found a clonal rearrangement of the Ti beta 1 and Ti gamma genes in both LGCL patients. In contrast, no clonal rearrangements of Ti beta or Ti gamma genes were detected in lymphocytes from the FS patients. These results indicate that FS patients are heterogeneous in their phenotype and that one subset exhibits polyclonal expansion of an unusual lymphocyte subset.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3102595

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  9 in total

1.  Lymphocytosis of large granular lymphocytes associated with anemia and neutropenia: proof of monoclonality of the LGL-population, but benign clinical course.

Authors:  S Serke; A Neubauer; D Huhn
Journal:  Klin Wochenschr       Date:  1989-06-01

2.  Phenotypic and genotypic analysis of mononuclear cells from patients with Felty's syndrome.

Authors:  M J Ahern; P J Roberts-Thomson; J Bradley; C Story; P Seshadri
Journal:  Ann Rheum Dis       Date:  1990-02       Impact factor: 19.103

Review 3.  T-cell and natural killer-cell large granular lymphocyte leukemia neoplasias.

Authors:  Rebecca J Watters; Xin Liu; Thomas P Loughran
Journal:  Leuk Lymphoma       Date:  2011-07-13

4.  Retrovirus in salivary glands from patients with Sjögren's syndrome.

Authors:  S Yamano; J N Renard; F Mizuno; Y Narita; Y Uchida; H Higashiyama; H Sakurai; I Saito
Journal:  J Clin Pathol       Date:  1997-03       Impact factor: 3.411

5.  TCR1+ large granular lymphocyte proliferation in rheumatoid arthritis.

Authors:  J G Kuipers; R Jacobs; A Kemper; H Zeidler; R E Schmidt
Journal:  Rheumatol Int       Date:  1994       Impact factor: 2.631

6.  Coexistent Felty's syndrome and palindromic rheumatism.

Authors:  R E Alvillar; L O'Grady; D Robbins
Journal:  Ann Rheum Dis       Date:  1991-12       Impact factor: 19.103

7.  Detection of Epstein-Barr virus DNA by polymerase chain reaction in blood and tissue biopsies from patients with Sjogren's syndrome.

Authors:  I Saito; B Servenius; T Compton; R I Fox
Journal:  J Exp Med       Date:  1989-06-01       Impact factor: 14.307

8.  Differentiation in vitro of T3+ large granular lymphocytes with characteristic cytotoxic activity from an isolated hematopoietic progenitor colony.

Authors:  N Minato; M Hattori; T Sudo; S Kano; Y Miura; J Suda; T Suda
Journal:  J Exp Med       Date:  1988-03-01       Impact factor: 14.307

Review 9.  Biology of natural killer cells.

Authors:  G Trinchieri
Journal:  Adv Immunol       Date:  1989       Impact factor: 3.543

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.